Bringing Healthcare Segmentations to Life With GenAI-Powered Persona

In the high-stakes world of pharmaceuticals, effective marketing hinges on understanding diverse healthcare professionals' intricate needs and motivations. Generative AI, ushering in a new era of possibility with the advent of the persona bot, offers a transformative solution to activate segmentation studies by injecting a much-needed dose of dynamism.

Persona bots, fueled by sophisticated algorithms and trained on robust datasets, embody the attitudes, behaviors, and preferences of real-world doctors, patients, and pharmacists. By transforming static reports into dynamic and interactive tools, these AI-powered avatars enable marketers to engage in interactive ‘dialogues’, providing deeper understanding and real-time feedback. However, realizing this potential requires careful planning, ethical considerations, and a commitment to continuous learning and adaptation.

In this article, we explore persona bots' existing and promising applications in healthcare market research, including virtual focus groups, streamlined message testing, and optimizing omnichannel strategies. We also analyze emerging trends in this field, including the potential of multimodal inputs and outputs and VR.

Ipsos’ new solution, Healthcare PersonaBot, is available now. Watch the video to see how Healthcare PersonaBot can unlock the full potential of your healthcare segmentation!

Healthcare Uncovered Podcast

In this episode of Ipsos' podcast series "Healthcare Uncovered", we are joined by Mario Menti, Сhief Technology Officer of the Healthcare team. Join us for an insightful discussion on the leaps made in generative AI in 2024, their implications on healthcare and life sciences, and a look into the potential future of AI in these sectors. Our guest expert reflects on the diverse applications of AI, from administrative functions to drug discovery and patient care. Listen in as we delve into the challenges and opportunities presented by this rapidly developing GenAI.

Also available on Apple Podcasts